-transparent.png){kind=logo}
Immunotherapy using bacille Calmette-Guérin (BCG) has gained increasing acceptance in the management of superficial bladder cancer. Systemic reactions after intravesical instillation of BCG are rare. However, when the therapy is complicated, the lung often becomes involved. Since the pathogenesis of lung infiltrates after immunotherapy is unknown, we report on a patient who developed a lung infiltrate after receiving BCG immunotherapy for bladder cancer. The infectious etiology was established by culture confirmation of a BCG strain in the bronchoalveolar lavage fluid.
Related Publications
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
April 2005,
Canadian respiratory journal,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
November 2007,
Japanese journal of infectious diseases,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
January 2013,
Indian journal of urology : IJU : journal of the Urological Society of India,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
August 2014,
Urology,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
June 2002,
Postgraduate medical journal,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
March 1997,
The Pediatric infectious disease journal,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
September 2000,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
October 2015,
The archives of bone and joint surgery,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
March 1987,
The American review of respiratory disease,
D Kirsten, and
U Rieger, and
K H Schröder, and
A Böhle, and
H Magnussen
June 1996,
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
